- Drug Pipelines
- January 2022
- 30 Pages
Global
From €449EUR$500USD£386GBP
- Drug Pipelines
- January 2022
- 30 Pages
Global
From €449EUR$500USD£386GBP
- Report
- January 2025
- 157 Pages
Global
From €3724EUR$4,150USD£3,205GBP
From €1880EUR$2,095USD£1,618GBP
€3580EUR$3,990USD£3,081GBP
From €1880EUR$2,095USD£1,618GBP
€3580EUR$3,990USD£3,081GBP
- Report
- May 2025
United States
From €1880EUR$2,095USD£1,618GBP
€3580EUR$3,990USD£3,081GBP
- Report
- May 2025
United Kingdom
From €1880EUR$2,095USD£1,618GBP
€3580EUR$3,990USD£3,081GBP
- Report
- May 2025
North America
From €1880EUR$2,095USD£1,618GBP
€3580EUR$3,990USD£3,081GBP
From €1880EUR$2,095USD£1,618GBP
€3580EUR$3,990USD£3,081GBP
- Report
- May 2025
Middle East
From €1880EUR$2,095USD£1,618GBP
€3580EUR$3,990USD£3,081GBP
- Report
- May 2025
Asia Pacific
From €1880EUR$2,095USD£1,618GBP
€3580EUR$3,990USD£3,081GBP
From €1880EUR$2,095USD£1,618GBP
€3580EUR$3,990USD£3,081GBP
- Report
- May 2025
United States
From €1880EUR$2,095USD£1,618GBP
€3580EUR$3,990USD£3,081GBP
- Report
- May 2025
North America
From €1880EUR$2,095USD£1,618GBP
€3580EUR$3,990USD£3,081GBP
From €1880EUR$2,095USD£1,618GBP
€3580EUR$3,990USD£3,081GBP
- Report
- May 2025
Middle East
From €1880EUR$2,095USD£1,618GBP
€3580EUR$3,990USD£3,081GBP
- Report
- May 2025
Asia Pacific
From €1880EUR$2,095USD£1,618GBP
€3580EUR$3,990USD£3,081GBP
- Report
- April 2025
Europe
From €3580EUR$3,990USD£3,081GBP
- Report
- April 2025
Europe
From €3580EUR$3,990USD£3,081GBP
- Report
- October 2024
- 88 Pages
Global
From €3500EUR$4,178USD£3,118GBP

The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally.
The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more